Global Fund-supported programmes contribution to international targets and the Millennium Development Goals: an initial analysis.
OBJECTIVE
The Global Fund to Fight AIDS, Tuberculosis and Malaria is one of the largest funders to fight these diseases. This paper discusses the programmatic contribution of Global Fund-supported programmes towards achieving international targets and Millennium Development Goals, using data from Global Fund grants.


METHODS
Results until June 2006 of 333 grants supported by the Global Fund in 127 countries were aggregated and compared against international targets for HIV/AIDS, tuberculosis and malaria. Progress reports to the Global Fund secretariat were used as a basis to calculate results. Service delivery indicators for antiretrovirals (ARV) for HIV/AIDS, case detection under the DOTS strategy for tuberculosis (DOTS) and insecticide-treated nets (ITNs) for malaria prevention were selected to estimate programmatic contributions to international targets for the three diseases. Targets of Global Fund-supported programmes were projected based on proposals for Rounds 1 to 4 and compared to international targets for 2009.


RESULTS
Results for Global Fund-supported programmes total 544,000 people on ARV, 1.4 million on DOTS and 11.3 million for ITNs by June 2006. Global Fund-supported programmes contributed 18% of international ARV targets, 29% of DOTS targets and 9% of ITNs in sub-Saharan Africa by mid-2006. Existing Global Fund-supported programmes have agreed targets that are projected to account for 19% of the international target for ARV delivery expected for 2009, 28% of the international target for DOTS and 84% of ITN targets in sub-Saharan Africa.


CONCLUSIONS
Global Fund-supported programmes have already contributed substantially to international targets by mid-2006, but there is a still significant gap. Considerably greater financial support is needed, particularly for HIV, in order to achieve international targets for 2009.
Komatsu
Ryuichi
R
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland. ryuichi.komatsu@theglobalfund.org
Low-Beer
Daniel
D
Schwartländer
Bernhard
B
D044966:Anti-Retroviral Agents / Q000600:supply & distribution; D023801:Directly Observed Therapy; D005381:Financing, Organized / Q000191:economics / Q000458:organization & administration*; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control; D006801:Humans; D007390:International Agencies / Q000191:economics / Q000458:organization & administration*; D008288:Malaria / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control; D015397:Program Evaluation; D014376:Tuberculosis / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control
D044966:Anti-Retroviral Agents